Bank of America
NVLN

Bank of America’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Bank of America’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,296
Closed -$1K – 7714
2019
Q3 		$1K Sell
1,296
-1,310
-50% -$949 ﹤0.01% 7209
2019
Q2 		$2K Buy
2,606
+1,154
+79% +$1.28K ﹤0.01% 6986
2019
Q1 		$2K Hold
1,452
– – ﹤0.01% 6940
2018
Q4 		$1K Sell
1,452
-213
-13% -$241 ﹤0.01% 7041
2018
Q3 		$5K Sell
1,665
-10,857
-87% -$38.4K ﹤0.01% 6851
2018
Q2 		$46K Buy
12,522
+10,278
+458% +$41.3K ﹤0.01% 6194
2018
Q1 		$8K Sell
2,244
-1,019
-31% -$4.32K ﹤0.01% 6684
2017
Q4 		$10K Sell
3,263
-4,139
-56% -$19.9K ﹤0.01% 6620
2017
Q3 		$52K Buy
7,402
+305
+4% +$2.44K ﹤0.01% 5929
2017
Q2 		$66K Sell
7,097
-950
-12% -$9.15K ﹤0.01% 5773
2017
Q1 		$87K Sell
8,047
-703
-8% -$7.18K ﹤0.01% 5680
2016
Q4 		$74K Buy
+8,750
New +$77.5K ﹤0.01% 5760

Other funds holding NVLN

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

Bank of America's NVLN Position: Q4 2019 in Review

Bank of America sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q4 2019, closing a stake of 1,296 shares — an estimated $1K sold.

Bank of America first reported a position in NVLN in Q4 2016 and held it in 12 quarters. The position peaked at $87K in Q1 2017. 7 funds tracked by Wall St. Rank hold NVLN as of Q4 2019.

  • Bank of America reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q4 2019 after selling out during the quarter.
  • Bank of America sold 1,296 Novelion Therapeutics Inc. Common Shares shares in Q4 2019, an estimated $1K.
  • Bank of America first reported a position in Novelion Therapeutics Inc. Common Shares in Q4 2016 and held it in 12 quarters.
  • Bank of America's Novelion Therapeutics Inc. Common Shares position peaked at $87K in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q4 2019.

Based on Bank of America's 13F filing for Q4 2019, filed 14 Feb 2020.